NCT00200044

Brief Summary

The purpose of the study is to demonstrate the intended use of the Gatekeeper Reflux Repair System to provide symptomatic relief is subjects with gastroesophageal reflux disease.

Trial Health

60
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
143

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Dec 2002

Longer than P75 for not_applicable

Geographic Reach
2 countries

11 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2002

Completed
2.8 years until next milestone

First Submitted

Initial submission to the registry

September 12, 2005

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 20, 2005

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2006

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2008

Completed
Last Updated

July 13, 2009

Status Verified

July 1, 2009

Enrollment Period

3.5 years

First QC Date

September 12, 2005

Last Update Submit

July 10, 2009

Conditions

Keywords

GERD

Outcome Measures

Primary Outcomes (1)

  • Reduction in serious device and procedure related adverse device effects.

    6 months

Secondary Outcomes (1)

  • Improvement in espophageal pH

    6 months

Study Arms (2)

Sham

SHAM COMPARATOR

This arm of the study has the procedure but does not get the Gatekeeper prostheses. The Sham arm has the option to cross-over to the Treatment arm at the 6-month visit.

Device: Gatekeeper Reflux Repair System

Treatment

ACTIVE COMPARATOR

The treatment arm has the Gatekeeper devices implanted.

Device: Gatekeeper Reflux Repair System

Interventions

The Gatekeeper System™ consists of a specialized 16-mm overtube assembly, a 2.4-mm diameter prosthesis delivery system (1-mm diameter needle, dilator, and 2.4-mm diameter sheath), a pushrod assembly and Gatekeeper Prosthesis. Up to 4 prostheses will be implanted at the initial procedure and retreatment with up to four more prostheses will be allowed at 3-months if the subject has a GERD HRQL score \>15.

Also known as: Gatekeeper
ShamTreatment

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subjects diagnosed with GERD with symptomatic improvement on PPIs.
  • Subjects who have demonstrated a baseline 24 Hour pH ≥ 4% time with pH ≤ 4.0.
  • Subjects with a baseline GERD-HRQL heartburn score of ≤11 on PPI and ≥ 20 off PPI.

You may not qualify if:

  • Extensive Barrett's Esophagus (\> 2 cm).
  • Esophagitis (LA Classification Grades C or D).
  • Previous history of gastroesophageal surgery, anti-reflux procedures, or gastroesophageal or gastric cancer.
  • Large hiatal hernia (\> 3 cm).
  • Current complaints of clinical dysphagia evidenced by greater than one occurrence per month.
  • Esophageal strictures
  • Esophageal or gastric varices

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (11)

Contact Medtronic for specific site information

San Francisco, California, 94115, United States

Location

Contact Medtronic for specific site information

Atlanta, Georgia, 30322, United States

Location

Contact Medtronic for specific site information

Chicago, Illinois, 60611, United States

Location

Contact Medtronic for specific site information

Indianapolis, Indiana, 46202, United States

Location

Contact Medtronic for specific site information

Lexington, Kentucky, 40536, United States

Location

Contact Medtronic for specific site information

St Louis, Missouri, 63110, United States

Location

Contact Medtronic for specific site information

Lebanon, New Hampshire, 03756, United States

Location

Contact Medtronic for specific site information

New York, New York, 10021, United States

Location

Contact Medtronic for specific site information

Knoxville, Tennessee, 37909, United States

Location

Contact Medtronic for specific site information

Milwaukee, Wisconsin, 53233, United States

Location

Contact Medtronic for specific site information

Amsterdam, Netherlands

Location

MeSH Terms

Conditions

Gastroesophageal Reflux

Condition Hierarchy (Ancestors)

Esophageal Motility DisordersDeglutition DisordersEsophageal DiseasesGastrointestinal DiseasesDigestive System Diseases

Study Officials

  • Glen Lehman

    Indiana University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY

Study Record Dates

First Submitted

September 12, 2005

First Posted

September 20, 2005

Study Start

December 1, 2002

Primary Completion

June 1, 2006

Study Completion

June 1, 2008

Last Updated

July 13, 2009

Record last verified: 2009-07

Locations